SenesTech, Inc. (NASDAQ:SNES) Sees Significant Decline in Short Interest

SenesTech, Inc. (NASDAQ:SNES) was the target of a significant decline in short interest in the month of July. As of July 15th, there was short interest totalling 42,200 shares, a decline of 90.7% from the June 30th total of 454,800 shares. Approximately 0.8% of the shares of the company are short sold. Based on an average trading volume of 10,800 shares, the days-to-cover ratio is presently 3.9 days.

SenesTech Stock Up 12.7 %

Shares of SNES traded up $0.54 during trading hours on Thursday, hitting $4.83. The stock had a trading volume of 66,606 shares, compared to its average volume of 29,946. The company’s fifty day moving average is $6.19 and its two-hundred day moving average is $7.71. The company has a quick ratio of 5.69, a current ratio of 6.91 and a debt-to-equity ratio of 0.03. SenesTech has a 52 week low of $4.00 and a 52 week high of $115.20.

SenesTech (NASDAQ:SNES) last posted its earnings results on Thursday, May 9th. The company reported ($3.60) earnings per share for the quarter, missing the consensus estimate of ($3.40) by ($0.20). The firm had revenue of $0.42 million during the quarter, compared to the consensus estimate of $0.43 million. SenesTech had a negative return on equity of 181.46% and a negative net margin of 545.82%. During the same period in the previous year, the company posted ($158.50) EPS. On average, equities analysts anticipate that SenesTech will post -1.1 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

SNES has been the topic of a number of research reports. StockNews.com initiated coverage on shares of SenesTech in a research report on Saturday, July 20th. They set a “sell” rating on the stock. HC Wainwright reissued a “buy” rating and issued a $35.00 price target on shares of SenesTech in a report on Tuesday, May 14th.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in SenesTech stock. McAdam LLC bought a new stake in shares of SenesTech, Inc. (NASDAQ:SNES) during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 64,348 shares of the company’s stock, valued at approximately $44,000. McAdam LLC owned 1.25% of SenesTech at the end of the most recent quarter. Hedge funds and other institutional investors own 5.19% of the company’s stock.

About SenesTech

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.